Switch theme
Sign up to access all valuation multiples
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
2014
312K+
LTM Revenue $151B
LTM EBITDA $3.8B
$38.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Walgreens Boots Alliance has a last 12-month revenue (LTM) of $151B and a last 12-month EBITDA of $3.8B.
In the most recent fiscal year, Walgreens Boots Alliance achieved revenue of $148B and an EBITDA of -$11.3B.
Walgreens Boots Alliance expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Walgreens Boots Alliance valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $151B | XXX | $148B | XXX | XXX | XXX |
| Gross Profit | $26.1B | XXX | $26.5B | XXX | XXX | XXX |
| Gross Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA | $3.8B | XXX | -$11.3B | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | -8% | XXX | XXX | XXX |
| EBIT | $2.1B | XXX | -$1.6B | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | -1% | XXX | XXX | XXX |
| Net Profit | $1.7B | XXX | -$8.6B | XXX | XXX | XXX |
| Net Margin | 1% | XXX | -6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $8.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Walgreens Boots Alliance's stock price is $11.
Walgreens Boots Alliance has current market cap of $9.7B, and EV of $38.7B.
See Walgreens Boots Alliance trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $38.7B | $9.7B | XXX | XXX | XXX | XXX | $1.96 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Walgreens Boots Alliance has market cap of $9.7B and EV of $38.7B.
Walgreens Boots Alliance's trades at 0.3x EV/Revenue multiple, and -6.1x EV/EBITDA.
Equity research analysts estimate Walgreens Boots Alliance's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Walgreens Boots Alliance has a P/E ratio of 5.8x.
See valuation multiples for Walgreens Boots Alliance and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9.7B | XXX | $9.7B | XXX | XXX | XXX |
| EV (current) | $38.7B | XXX | $38.7B | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 10.3x | XXX | -6.1x | XXX | XXX | XXX |
| EV/EBIT | 18.5x | XXX | -92.5x | XXX | XXX | XXX |
| EV/Gross Profit | 1.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 5.8x | XXX | -1.8x | XXX | XXX | XXX |
| EV/FCF | -98.9x | XXX | -103.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialWalgreens Boots Alliance's last 12 month revenue growth is 2%
Walgreens Boots Alliance's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Walgreens Boots Alliance's rule of 40 is -2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Walgreens Boots Alliance's rule of X is 7% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Walgreens Boots Alliance and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Growth | -9% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -2% | XXX | -3% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 7% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Walgreens Boots Alliance acquired XXX companies to date.
Last acquisition by Walgreens Boots Alliance was XXXXXXXX, XXXXX XXXXX XXXXXX . Walgreens Boots Alliance acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Walgreens Boots Alliance founded? | Walgreens Boots Alliance was founded in 2014. |
| Where is Walgreens Boots Alliance headquartered? | Walgreens Boots Alliance is headquartered in United States of America. |
| How many employees does Walgreens Boots Alliance have? | As of today, Walgreens Boots Alliance has 312K+ employees. |
| Who is the CEO of Walgreens Boots Alliance? | Walgreens Boots Alliance's CEO is Mr. Timothy Charles Wentworth. |
| Is Walgreens Boots Alliance publicy listed? | Yes, Walgreens Boots Alliance is a public company listed on NAS. |
| What is the stock symbol of Walgreens Boots Alliance? | Walgreens Boots Alliance trades under WBA ticker. |
| When did Walgreens Boots Alliance go public? | Walgreens Boots Alliance went public in 1985. |
| Who are competitors of Walgreens Boots Alliance? | Similar companies to Walgreens Boots Alliance include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Walgreens Boots Alliance? | Walgreens Boots Alliance's current market cap is $9.7B |
| What is the current revenue of Walgreens Boots Alliance? | Walgreens Boots Alliance's last 12 months revenue is $151B. |
| What is the current revenue growth of Walgreens Boots Alliance? | Walgreens Boots Alliance revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Walgreens Boots Alliance? | Current revenue multiple of Walgreens Boots Alliance is 0.3x. |
| Is Walgreens Boots Alliance profitable? | Yes, Walgreens Boots Alliance is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Walgreens Boots Alliance? | Walgreens Boots Alliance's last 12 months EBITDA is $3.8B. |
| What is Walgreens Boots Alliance's EBITDA margin? | Walgreens Boots Alliance's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Walgreens Boots Alliance? | Current EBITDA multiple of Walgreens Boots Alliance is 10.3x. |
| What is the current FCF of Walgreens Boots Alliance? | Walgreens Boots Alliance's last 12 months FCF is -$391M. |
| What is Walgreens Boots Alliance's FCF margin? | Walgreens Boots Alliance's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Walgreens Boots Alliance? | Current FCF multiple of Walgreens Boots Alliance is -98.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
